DAY301 clinical trials

To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors

This study is testing a new medicine called DAY301 for advanced cancers that have spread. It aims to see how safe it is, what side effects it causes, and if it can help shrink tumours. It's an early-stage study.